| Literature DB >> 11261324 |
C F Eisenbeis1, D Winn, S Poelman, C V Polsky, J H Rubenstein, O I Olopade.
Abstract
The cytokine growth factor, G-CSF (granulocyte colony-stimulating factor), is commonly used in oncologic practice and is generally believed to be a safe agent to administer. We describe here a case of pulmonary toxicity associated with the concurrent administration of G-CSF and doxorubicin. We contend that G-CSF contributed to the life-threatening lung injury in our patient, and discuss additional reports in the literature of pulmonary toxicity associated with the use of this agent.Entities:
Mesh：
Substances：
Year: 2001 PMID： 11261324 PMCID： PMC7101872 DOI： 10.1007/s002770000232
Source DB: PubMed Journal: Ann Hematol ISSN： 0939-5555 Impact factor: 3.673